IDEX (NYSE:IEX) Downgraded by StockNews.com to “Hold”

StockNews.com cut shares of IDEX (NYSE:IEXFree Report) from a buy rating to a hold rating in a report released on Thursday.

Several other analysts have also recently commented on the company. Robert W. Baird lowered their target price on IDEX from $260.00 to $256.00 and set an outperform rating on the stock in a research report on Thursday, April 25th. Stifel Nicolaus raised IDEX from a hold rating to a buy rating and raised their price target for the company from $215.00 to $265.00 in a report on Thursday, February 8th. Oppenheimer upped their price objective on shares of IDEX from $245.00 to $252.00 and gave the stock an outperform rating in a report on Thursday, April 18th. Royal Bank of Canada reiterated an outperform rating and issued a $255.00 target price on shares of IDEX in a research report on Thursday, March 21st. Finally, Citigroup boosted their price target on shares of IDEX from $254.00 to $277.00 and gave the stock a buy rating in a research report on Monday, April 8th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, IDEX presently has a consensus rating of Moderate Buy and a consensus price target of $250.71.

Get Our Latest Stock Analysis on IDEX

IDEX Stock Performance

Shares of NYSE:IEX traded up $1.91 during trading on Thursday, hitting $222.33. 210,484 shares of the company traded hands, compared to its average volume of 378,721. The stock has a market capitalization of $16.83 billion, a price-to-earnings ratio of 29.37, a PEG ratio of 2.21 and a beta of 0.99. IDEX has a one year low of $183.76 and a one year high of $246.36. The company has a quick ratio of 2.45, a current ratio of 3.37 and a debt-to-equity ratio of 0.37. The business’s fifty day moving average is $235.22 and its 200-day moving average is $217.49.

IDEX (NYSE:IEXGet Free Report) last issued its earnings results on Tuesday, April 23rd. The industrial products company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.76 by $0.12. IDEX had a return on equity of 17.60% and a net margin of 17.89%. The firm had revenue of $801.00 million for the quarter, compared to analyst estimates of $807.52 million. During the same period last year, the company earned $2.09 earnings per share. The firm’s revenue for the quarter was down 5.3% on a year-over-year basis. As a group, equities analysts predict that IDEX will post 8.33 earnings per share for the current fiscal year.

Institutional Investors Weigh In On IDEX

A number of institutional investors and hedge funds have recently bought and sold shares of IEX. Planned Solutions Inc. bought a new stake in shares of IDEX in the 4th quarter worth approximately $33,000. Riverview Trust Co bought a new position in shares of IDEX in the first quarter valued at $35,000. Quarry LP acquired a new stake in shares of IDEX during the 4th quarter valued at $36,000. EdgeRock Capital LLC bought a new stake in shares of IDEX during the 4th quarter worth $48,000. Finally, VisionPoint Advisory Group LLC acquired a new position in shares of IDEX in the 4th quarter worth $50,000. 97.96% of the stock is owned by institutional investors and hedge funds.

About IDEX

(Get Free Report)

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries.

Further Reading

Analyst Recommendations for IDEX (NYSE:IEX)

Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.